Ani Pharmaceuticals (ANIP) Cost of Revenue (2012 - 2026)
Ani Pharmaceuticals' Cost of Revenue was $100.16 million in Q2 2026, up 34.2% from $74.62 million a year earlier and up 7.0% from the prior quarter.
Ani Pharmaceuticals (ANIP) Cost of Revenue (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ani Pharmaceuticals' Cost of Revenue was $387.4 million through Jun 30, 2026, up 33.1% year-over-year; for FY2025, it was $341.31 million, up 36.4% from FY2024.
- Cost of Revenue has now increased for six consecutive years, with a five-year compound annual growth rate of 31.4% (FY2020 to FY2025).
- In earlier years, Cost of Revenue was $250.21 million in FY2024 (+37.8%), $181.51 million in FY2023 (+30.8%), $138.79 million in FY2022 (+37.9%) and $100.61 million in FY2021 (+15.4%).
- Quarterly Cost of Revenue has moved between $24.41 million (Q3 2021) and $100.27 million (Q4 2025) over five years.
- Compared with a year earlier, Cost of Revenue has increased for 21 straight quarters, with growth averaging 36.8% over the last eight quarters.
- The year-over-year growth in Cost of Revenue has ranged between 7.2% (Q4 2022) and 71.5% (Q1 2022) over the last five years.
- Per Business Quant data, ANIP's Cost of Revenue in the three quarters before Q2 2026 was $93.58 million (Q1 2026), $100.27 million (Q4 2025) and $93.39 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn | 100.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.16 Mn |
| Mar 31, 2026 | 93.58 Mn |
| Dec 31, 2025 | 100.27 Mn |
| Sep 30, 2025 | 93.39 Mn |
| Jun 30, 2025 | 74.62 Mn |
| Mar 31, 2025 | 73.04 Mn |
| Dec 31, 2024 | 80.28 Mn |
| Sep 30, 2024 | 63.08 Mn |
| Jun 30, 2024 | 57.70 Mn |
| Mar 31, 2024 | 49.16 Mn |
| Dec 31, 2023 | 53.42 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 42.28 Mn |
| Mar 31, 2023 | 37.71 Mn |
| Dec 31, 2022 | 36.33 Mn |
| Sep 30, 2022 | 32.89 Mn |
| Jun 30, 2022 | 35.29 Mn |
| Mar 31, 2022 | 34.27 Mn |
| Dec 31, 2021 | 33.90 Mn |
| Sep 30, 2021 | 24.41 Mn |
Ani Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();